Filter news by date News Tags - Any -News storyPress release Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year2024202320222021202020192018201720162015201420132012201120102009200820072006 Apply 4 . 24 . 2024 Press release Galderma delivers a strong start to the year with record net sales of over 1 billion USD for the first quarter and 12.4% year-on-year growth 4 . 9 . 2024 News story An organization built on uniqueness 3 . 27 . 2024 News story Celebrating Galderma’s listing on the SIX Swiss Exchange 3 . 26 . 2024 Press release Galderma announces full exercise of over-allotment option 3 . 21 . 2024 Press release Galderma prices IPO at CHF 53 per share and will start trading on the SIX Swiss Exchange tomorrow 3 . 19 . 2024 Press release AMWC 2024: Galderma to share new data from its leading injectable aesthetic portfolio 3 . 19 . 2024 News story AMWC 2024: Scientific presentations supported by Galderma 3 . 13 . 2024 Press release Galderma launches IPO on the SIX Swiss Exchange and sets price range 3 . 13 . 2024 News story Dr. Flor A. Mayoral: A story of creativity, passion and dermatological innovation with Galderma 3 . 12 . 2024 News story We’re inspired by our people 3 . 10 . 2024 Press release Galderma @ AAD 2024: new data demonstrate the long-term efficacy of nemolizumab in prurigo nodularis and its durability in atopic dermatitis 3 . 6 . 2024 Press release Galderma Announces Intention to Float on the SIX Swiss Exchange 2 . 29 . 2024 Press release Galderma announces record 2023 net sales of over 4 B USD and significant core EBITDA margin expansion Pagination Next page Next Page